Cite
HARVARD Citation
Fleischmann, R. et al. (n.d.). SAT0575 Safety and efficacy of lutikizumab (ABT-981), an anti–interleukin-1 alpha/beta dual variable domain (DVD) immunoglobulin, in subjects with knee osteoarthritis: results from the randomised, double-blind, placebo-controlled, parallel-group phase 2 trial. Annals of the rheumatic diseases. pp. 1141-1142. [Online].